In CCA, SCD-1 expression is upregulated, and the highly specific SCD-1 inhibitor SSI-4 can retard CCA growth and proliferation and has synergistic antitumor effects with GEM and cisplatin [104]. This evidence concerns the gene SCD and cholangiocarcinoma.